Antengene (Hangzhou) Biologics Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Antengene (Hangzhou) Biologics Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Trial of ATG-101 in Patients With Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas (NCT05490043) | Antengene (Hangzhou) Biologics Co., Ltd. | 2022-01-30 |
Track Antengene (Hangzhou) Biologics Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.